These results were confirmed by analyses of caspase-3 activation, which further revealed that belimumab prevents the anti-apoptotic effect of BAFF on CLL cells exposed to the small molecule inhibitors (Figure 4B,D). This evidence concerns the gene CASP3 and B-cell chronic lymphocytic leukemia.